Atlas Trials

Preliminary Study on the Clinical Effect of Recombinant Human Brain Natriuretic Peptide on Sepsis Complicated With Heart Failure

Clinical trial NCT05111769 · UNKNOWN

Trial details

NCT number
NCT05111769
Sponsor
Shanghai Zhongshan Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Sepsis
Start date
2021-12-01
Primary completion
2023-12-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.